All are used. In this sense, the taxanes, irinotecan, oxaliplatin and promising drugs are considering cross-resistance to cisplatin or 5-FU. The study of Korean Cancer Launches New Phase III randomized, multicenter trial evaluating the efficacy of paclitaxel versus irinotecan in patients with recurrent or metastatic gastric cancer GSK461364 PLK inhibitor to evaluate the progress made by a first-line therapy, the taxanes closing T or irinotecan . Acknowledgements This study by a grant from the Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea has been funded. Fifty-nine of 102 patients, for an indefinite tchen dumplings had follow-up chest CT, and six patients were closing Lich diagnosed with lung metastases. The histological diagnosis was best in four out of six patients CONFIRMS.
Three thoracoscopic resection GSK1070916 942918-07-2 video-assisted surgery and underwent a bilobectomy of the lung area. Two were from the radiology department without biopsy on dumplings tchen size E increases or decreases based diagnoses. The clinical features of patients in the metastatic and non-metastatic are summarized in Table II. There were no significant differences between groups regarding gender, age, the distance between the tumor and the anal margin, and the pr Operative carcinoembryonic antigen level, or multiple pulmonary nodules. The Gr E of lung nodules, pathologic N status, positive lymph node status and the number of positive lymph nodes were significant risk factors for lung metastases. There was no statistically significant differences between the two groups in relation to other pathological conditions or treatment.
Risk data were summarized for the metastatic group. The average size E of pulmonary metastatic nodes in the group was 6.25 mm. The ROC curve showed that the best limit on the size E of pulmonary nodules with a sensitivity of 5.7 mm t of 66.7% and a specificity of t was 81.1%. At this border, was the bottle Surface under the ROC curve of 0.739. In the group of metastases, five patients who had positive lymph node status Re U adjuvant chemotherapy. Two of these five patients had again U is an oxaliplatin-based chemotherapy and three patients had an intravenous Se or oral chemotherapy with 5-fluorouracil. One patient who had a lymph node status was not again U of adjuvant chemotherapy. The median of the Best Confirmation of metastasis was 5.5 months.
The interval for metastases in patients who again U FOLFOX4 as adjuvant chemotherapy in patients who again U 5-FU chemotherapy or no adjuvant chemotherapy, but the difference was not statistically significant. The interval Best Confirmation of metastases in patients who again U Including some adjuvant chemotherapy Lich different 5-FU or FOLFOX4 did not differ significantly from that of patients who had no adjuvant chemotherapy. There were no significant differences in the time frame for nodal status, or the size E of the lung nodules. Discussion since the introduction of the scanner helicopter Dal has become common in the 1990s and multidetector-row CT in the 1990s, the recognition of dumplings tchen only 1-2 mm in diameter, and patients are increasingly the CT chest object for the pr Operational. Therefore, appeared for an indeterminate lung nodules as a new concern. Previous studies